Literature DB >> 2671034

Fluoroimmunoassay studies with solubilized antigens from Borrelia burgdorferi.

K E Hechemy1, H L Harris, J A Wethers, R W Stevens, B R Stock, A A Reilly, J L Benach.   

Abstract

Sodium deoxycholate-solubilized Borrelia burgdorferi antigen was prepared for use in a solid-phase fluoroimmunoassay (FIA-L) to detect antibodies in Lyme disease. Serum specimens were tested by FIA-L and by a microimmunofluorescence test. The FIA-L results are comparable to those of the standard microimmunofluorescence test. The overall agreement was 0.98. Moreover, the FIA-L procedure is simple and rapid; fluorescence is objectively determined and is proportional to antibody titer.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2671034      PMCID： PMC267683          DOI： 10.1128/jcm.27.8.1854-1858.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  Analysis of growth and dose response curves.

Authors:  J E Grizzle; D M Allen
Journal:  Biometrics       Date:  1969-06       Impact factor: 2.571

2.  Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease.

Authors:  H Russell; J S Sampson; G P Schmid; H W Wilkinson; B Plikaytis
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

3.  The spirochetal etiology of Lyme disease.

Authors:  A C Steere; R L Grodzicki; A N Kornblatt; J E Craft; A G Barbour; W Burgdorfer; G P Schmid; E Johnson; S E Malawista
Journal:  N Engl J Med       Date:  1983-03-31       Impact factor: 91.245

4.  Lyme disease-a tick-borne spirochetosis?

Authors:  W Burgdorfer; A G Barbour; S F Hayes; J L Benach; E Grunwaldt; J P Davis
Journal:  Science       Date:  1982-06-18       Impact factor: 47.728

5.  A dot-immunobinding assay for monoclonal and other antibodies.

Authors:  R Hawkes; E Niday; J Gordon
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

6.  Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease.

Authors:  L A Magnarelli; J M Meegan; J F Anderson; W A Chappell
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

7.  Microimmunofluorescence test for the serological study of rocky mountain spotted fever and typhus.

Authors:  R N Philip; E A Casper; R A Ormsbee; M G Peacock; W Burgdorfer
Journal:  J Clin Microbiol       Date:  1976-01       Impact factor: 5.948

8.  Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities.

Authors:  A C Steere; S E Malawista; D R Snydman; R E Shope; W A Andiman; M R Ross; F M Steele
Journal:  Arthritis Rheum       Date:  1977 Jan-Feb

9.  Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease.

Authors:  R L Grodzicki; A C Steere
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

10.  Discovery of the Lyme disease spirochete and its relation to tick vectors.

Authors:  W Burgdorfer
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  6 in total

1.  Serological responses to Ehrlichia equi, Ehrlichia chaffeensis, and Borrelia burgdorferi in patients from New York State.

Authors:  S J Wong; G S Brady; J S Dumler
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Ovalbumin blocking improves sensitivity and specificity of immunoglobulin M immunoblotting for serodiagnosis of patients with erythema migrans.

Authors:  R Lange; H Bocklage; T Schneider; H W Kölmel; J Heesemann; H Karch
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

3.  Detection of borreliacidal antibodies in hamsters by using flow cytometry.

Authors:  K F Sachsenmeier; K Schell; L W Morrissey; D R Pennell; R M West; S M Callister; R F Schell
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

4.  Monoclonal antibody to native P39 protein from Borrelia burgdorferi.

Authors:  T J Sullivan; K E Hechemy; H L Harris; U H Rudofsky; W A Samsonoff; A J Peterson; B D Evans; S L Balaban
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

5.  Cross-reaction with Borrelia burgdorferi antigen of sera from patients with human immunodeficiency virus infection, syphilis, and leptospirosis.

Authors:  D Raoult; K E Hechemy; G Baranton
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

6.  Detection of borreliacidal antibody by using acridine orange and flow cytometry.

Authors:  L C Lim; Y F Liu; K Schell; S D Lovrich; S M Callister; R F Schell
Journal:  Clin Diagn Lab Immunol       Date:  1994-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.